Features

A watershed study samples deep ocean RNA viruses the world over and reveals 99 percent of them have yet to be discovered.

Digital tools, early detection, and better insurance policies can address the coming wave of cognitive decline.

Going from blood sample to diagnosis in the same work shift, rapid genomic sequencing proves its worth in clinical settings.

Rockfish, clams, tortoises, and other underwater Methuselahs harbor adaptations that could provide clues to unlocking our own longevity.

As psychedelic drugs are poised to join the mainstream, what is the role of the prescriber?

Dogs, ants, and other organisms that sniff out cancer could help train an AI to do the same.

An interview with MIT biologist David Sun Kong—on science, activism, and how biotechnology can empower ordinary people.

10% of women suffer from this painful condition, which often goes undiagnosed for years. This has to change.

Elephant skin walls, robotic flower houses, “Baubotanik” buildings, a treehouse on Mars, and the Mother Nature future of urban design.

Alto Neuroscience wants to use EEG brain biomarkers to better match the right treatment to a person’s needs.

Music and psychedelics go hand-in-hand. Could both have a healing effect?

London-based startup Wavepaths is creating a new kind of music technology explicitly designed for psychedelic therapy.

Insect-based foods, fuels, fertilizers, and antimicrobials will be a part of our future, like it or not.

Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?

An experimental drug that addresses anhedonia could increase the brain’s capacity to experience pleasure and herald a new era of precision medicine in psychiatry.